Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 2, 2023. (Total: 217537Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Neutropenia and FCGR3A[original query]
Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.
Internal medicine journal 2012 Oct 42 (10): 1113-9.
Keane C, Nourse J P, Crooks P, Nguyen-Van D, Mutsando H, Mollee P, Lea R A, Gandhi M
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013 Jan .
Paz-Ares L, Bálint B, de Boer RH, van Meerbeeck JP, Wierzbicki R, De Souza P, Galimi F, Haddad V, Sabin T, Hei YJ, Pan Y, Cottrell S, Hsu CP, Ramlau R
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma.
British journal of haematology 2014 May 165 (3): 375-81.
Tuscano Joseph M, Dutia Mrinal, Chee Karen, Brunson Ann, Reed-Pease Christine, Abedi Mehrdad, Welborn Jeanna, O'Donnell Robert
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
Hematological oncology 2016 Jun .
Ghesquières Hervé, Larrabee Beth R, Haioun Corinne, Link Brian K, Verney Aurélie, Slager Susan L, Ketterer Nicolas, Ansell Stephen M, Delarue Richard, Maurer Matthew J, Fitoussi Olivier, Habermann Thomas M, Peyrade Fréderic, Dogan Ahmet, Molina Thierry J, Novak Anne J, Tilly Hervé, Cerhan James R, Salles Gill
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).
Annals of oncology : official journal of the European Society for Medical Oncology 2017 9 28 (11): 2806-2812.
Martin P, Jung S-H, Pitcher B, Bartlett N L, Blum K A, Shea T, Hsi E D, Ruan J, Smith S E, Leonard J P, Cheson B
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.
Arthritis research & therapy 2017 Mar 19 (1): 44.
Ajeganova Sofia, Tesfa Daniel, Hägglund Hans, Fadeel Bengt, Vedin Inger, Zignego Anna Linda, Palmblad J
Genetic variations in low-to-medium-affinity Fc? receptors and autoimmune neutropenia in early childhood in a Danish cohort.
International journal of immunogenetics 2023 2 50 (2): 65-74.
Kløve-Mogensen Kirstine, Steffensen Rudi, Masmas Tania Nicole, Glenthøj Andreas, Jensen Christina Friis, Haunstrup Thure Mors, Ratcliffe Paul, Höglund Petter, Hasle Henrik, Nielsen Kaspar Re
TOP